Atlas Brown Inc. Buys 66 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atlas Brown Inc. lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,049 shares of the healthcare conglomerate’s stock after acquiring an additional 66 shares during the period. Atlas Brown Inc.’s holdings in UnitedHealth Group were worth $801,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of UNH. Unigestion Holding SA boosted its stake in UnitedHealth Group by 259.2% during the third quarter. Unigestion Holding SA now owns 3,800 shares of the healthcare conglomerate’s stock valued at $1,485,000 after buying an additional 2,742 shares during the period. Archford Capital Strategies LLC lifted its position in UnitedHealth Group by 7.2% during the third quarter. Archford Capital Strategies LLC now owns 3,788 shares of the healthcare conglomerate’s stock valued at $1,480,000 after purchasing an additional 256 shares during the period. Procyon Private Wealth Partners LLC lifted its position in UnitedHealth Group by 2.4% during the third quarter. Procyon Private Wealth Partners LLC now owns 5,613 shares of the healthcare conglomerate’s stock valued at $2,193,000 after purchasing an additional 129 shares during the period. Genesee Capital Advisors LLC purchased a new position in UnitedHealth Group in the third quarter valued at $815,000. Finally, First United Bank & Trust increased its holdings in UnitedHealth Group by 2.6% in the third quarter. First United Bank & Trust now owns 969 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 25 shares in the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.

Shares of UNH stock traded up $3.03 during trading hours on Thursday, hitting $450.16. The company had a trading volume of 2,248,836 shares, compared to its average volume of 2,940,181. The company’s fifty day moving average is $430.47 and its 200 day moving average is $418.01. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a fifty-two week low of $320.35 and a fifty-two week high of $466.00. The stock has a market capitalization of $423.98 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm had revenue of $72.34 billion for the quarter, compared to analyst estimates of $71.24 billion. During the same period in the prior year, the business posted $3.51 EPS. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be issued a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. UnitedHealth Group’s dividend payout ratio is currently 35.98%.

A number of research analysts have weighed in on the stock. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $435.00 to $475.00 and gave the company a “market perform” rating in a report on Monday, October 18th. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $473.00 to $476.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Cowen assumed coverage on shares of UnitedHealth Group in a research note on Thursday, September 9th. They set an “outperform” rating and a $478.00 target price for the company. Oppenheimer boosted their target price on shares of UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Finally, Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $478.00 to $520.00 and gave the stock an “overweight” rating in a research note on Monday, October 25th. One investment analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $477.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total transaction of $1,111,750.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 82,500 shares of company stock worth $36,855,125. 0.55% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Marijuana Stocks

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.